REPZYG
Live / Registered — Registered (as of 24 Sept 2024)
What this means for you
Registered since 24 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97052331
- Registration number
- 7510693
- Mark type
- Stylized text
- Filed
- 29 Sept 2021
- Published for opposition
- 09 Jul 2024
- Registered
- 24 Sept 2024
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
Prosecution history
- 24 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jul 2024 — PUBLISHED FOR OPPOSITION
- 19 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jun 2024 — CASE RETURNED TO EXAMINATION
- 06 Jun 2024 — NOTICE OF ALLOWANCE CANCELLED
- 10 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 May 2024 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 09 May 2024 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 09 May 2024 — ASSIGNED TO PETITION STAFF
- 29 Mar 2024 — PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
- 09 May 2024 — SOU EXTENSION 3 GRANTED
- 18 Apr 2024 — SOU EXTENSION 3 FILED
- 09 May 2024 — NOTICE OF REVIVAL - E-MAILED